Kurt H Kruger is Director of Qualigen Therapeutics, Inc.. Currently has a direct ownership of 18,000 shares of QLGN, which is worth approximately $3,060. The most recent transaction as insider was on Aug 19, 2021, when has been sold 8,000 shares (Common Stock) at a price of $1.23 per share, resulting in proceeds of $9,840. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18K
0% 3M change
0% 12M change
Total Value Held $3,060

Kurt H Kruger Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 19 2021
BUY
Open market or private purchase
$9,840 $1.23 p/Share
8,000 Added 30.77%
18,000 Common Stock
Dec 29 2020
BUY
Open market or private purchase
$11,760 $2.94 p/Share
4,000 Added 28.57%
10,000 Common Stock
Nov 23 2020
BUY
Open market or private purchase
$15,916 $3.46 p/Share
4,600 Added 43.4%
6,000 Common Stock
Nov 20 2020
BUY
Open market or private purchase
$4,970 $3.55 p/Share
1,400 Added 50.0%
1,400 Common Stock
KHK

Kurt H Kruger

Director
Carlsbad, CA

Track Institutional and Insider Activities on QLGN

Follow Qualigen Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells QLGN shares.

Notify only if

Insider Trading

Get notified when an Qualigen Therapeutics, Inc. insider buys or sells QLGN shares.

Notify only if

News

Receive news related to Qualigen Therapeutics, Inc.

Track Activities on QLGN